ATI-1777, a Topical Jak1/3 Inhibitor, May Benefit Atopic Dermatitis without Systemic Drug Exposure: Results from Preclinical Development and Phase 2a Randomized Control Study ATI-1777-AD-201.
局部用 Jak1/3 抑制剂 ATI-1777 可能在不进行全身用药的情况下使特应性皮炎受益：临床前开发和 2a 期随机对照研究 ATI-1777-AD-201 的结果
期刊:JID Innovations
影响因子:
doi:10.1016/j.xjidi.2023.100251
Changelian Paul, Xu Canxin, Mnich Steve, Hope Heidi, Kostecki Kourtney, Hirsch Jeff, Loh Chin-Yi, Anderson David, Blinn James, Hockerman Susan, Dick Evan, Smith Walter, Monahan Joseph, Raoof Tooraj, Forman Seth, Burt David, Barnes Brad, Gordon David, Walker Neal, Sudzina John, Tucker Stephen, Jacobsen Jon
